These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8621621)

  • 1. Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor.
    Ho G; Toomey JR; Broze GJ; Schwartz AL
    J Biol Chem; 1996 Apr; 271(16):9497-502. PubMed ID: 8621621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low density lipoprotein receptor-related protein can function independently from heparan sulfate proteoglycans in tissue factor pathway inhibitor endocytosis.
    Warshawsky I; Herz J; Broze GJ; Schwartz AL
    J Biol Chem; 1996 Oct; 271(42):25873-9. PubMed ID: 8824219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes.
    Ho G; Broze GJ; Schwartz AL
    J Biol Chem; 1997 Jul; 272(27):16838-44. PubMed ID: 9201990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
    Warshawsky I; Bu G; Mast A; Saffitz JE; Broze GJ; Schwartz AL
    J Clin Invest; 1995 Apr; 95(4):1773-81. PubMed ID: 7706485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
    Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
    J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.
    Warshawsky I; Broze GJ; Schwartz AL
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6664-8. PubMed ID: 7517557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo.
    Narita M; Bu G; Olins GM; Higuchi DA; Herz J; Broze GJ; Schwartz AL
    J Biol Chem; 1995 Oct; 270(42):24800-4. PubMed ID: 7559599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo.
    Ho G; Narita M; Broze GJ; Schwartz AL
    Blood; 2000 Mar; 95(6):1973-8. PubMed ID: 10706863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.
    Mast AE; Higuchi DA; Huang ZF; Warshawsky I; Schwartz AL; Broze GJ
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):577-83. PubMed ID: 9359432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein.
    Hamik A; Setiadi H; Bu G; McEver RP; Morrissey JH
    J Biol Chem; 1999 Feb; 274(8):4962-9. PubMed ID: 9988740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface.
    Kazama Y; Komiyama Y; Kisiel W
    Blood; 1993 Feb; 81(3):676-82. PubMed ID: 8381308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
    Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
    Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
    Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
    Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
    Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes.
    Willems GM; Janssen MP; Salemink I; Wun TC; Lindhout T
    Biochemistry; 1998 Mar; 37(10):3321-8. PubMed ID: 9521652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
    Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.